Analysis of mortality and risk factors associated with native valve endocarditis in drug users: the importance of vegetation size.

BACKGROUND Native valve endocarditis in drug-user patients had a microbiology, a frequency of involvement of different cardiac valves, and a prognosis that differ from those in non-drug users. A retrospective study of native valve endocarditis cases in intravenous drug users diagnosed from 1985 to 1999 in our institution was performed to analyze the inhospital mortality of drug users with native valve endocarditis and to identify factors predictive of mortality. METHODS All patients fulfilled the Duke's criteria for definite or probable endocarditis. Analysis of predictors of inhospital mortality was restricted to right-sided infective endocarditis (IE) with definite diagnosis and echocardiographic data. The following variables were analyzed: sex, HIV serostatus, CD4 cell count < 200/mm3, time of IE diagnosis (before 1993 or after 1993), previous valvulopathy, polymicrobial IE, fungal etiology (mixed or alone), neurological complication, arterial emboli, pulmonary emboli, congestive heart failure, vegetation size (VS) > 2 cm, and inhospital cardiac surgery. Logistic regression was used in a multivariate model to identify factors independently associated with mortality. Adjusted odds ratios (OR) and 95% CIs were examined. RESULTS Four hundred ninety-three cases of IE were diagnosed in this period. Two hundred twenty cases of native valve endocarditis in intravenous drug users were identified. Fourteen cases in this group died (6%). Mean time from diagnosis to death was 18.5 +/- 15 days (range, 3-52). Vegetation size was available in 111 cases. Univariate analysis identified the following variables associated with inhospital mortality in right-sided cases: VS > 2 cm and fungal etiology. In multivariate analysis, the variables associated with mortality that achieved statistical significance were size of vegetation > 2 cm (P = .014, OR 10.2, 95% CI 1.6-78.0) and fungal etiology (P = .009, OR 46.2, 95% CI 2.4-1100.9). CONCLUSIONS The main prognostic factors of inhospital mortality in right-sided IE in drug users in our series were VS > 2 cm and fungal etiology. The role of early surgery in these patients should be reevaluated.

[1]  E. Rapaport,et al.  Presentation, management, and follow-up evaluation of infective endocarditis in drug addicts. , 1981, American heart journal.

[2]  G. Hutchins,et al.  Quantification of regional myocardial perfusion by PET: rationale and first clinical results. , 1995, European heart journal.

[3]  V. Quagliarello,et al.  Endovascular infections arising from right-sided heart structures. , 1992, Cardiology clinics.

[4]  T. Burkert.  Infective Endocarditis at a Large Community Teaching Hospital, 1980–1990: A Review of 210 Episodes , 1993, Medicine.

[5]  S. Shafran,et al.  Infective endocarditis: review of 135 cases over 9 years. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  J. Mathew,et al.  Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. , 1995, Archives of internal medicine.

[7]  J. Gatell,et al.  Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users. , 1998, Archives of internal medicine.

[8]  L. Saravolatz,et al.  Polymicrobial infective endocarditis: an increasing clinical entity. , 1978, American heart journal.

[9]  A Mügge,et al.  Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. , 1989, Journal of the American College of Cardiology.

[10]  E. Antman,et al.  Guidelines for the management of patients with valvular heart disease: executive summary , 1998, Circulation.

[11]  Leonardo Mancini,et al.  Risk of embolization after institution of antibiotic therapy for infective endocarditis. , 2002, Journal of the American College of Cardiology.

[12]  A. Bolger,et al.  Prevention of bacterial endocarditis. , 1983, Medical times.

[13]  D. Durack,et al.  New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. , 1994, The American journal of medicine.

[14]  R. Frater,et al.  Influence of vegetation size on clinical outcome of right-sided infective endocarditis. , 1986, The American journal of medicine.

[15]  M E Ellis,et al.  Fungal endocarditis: evidence in the world literature, 1965-1995. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  J. Zamorano,et al.  Transesophageal echocardiography in right-sided endocarditis. , 1993, Journal of the American College of Cardiology.

[17]  D. Silverman,et al.  Endocarditis in an urban hospital in the 1990s. , 1996, Archives of internal medicine.

[18]  M P Weinstein,et al.  Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients. , 1990, The Journal of infectious diseases.

[19]  F Fedele,et al.  Role of transthoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves. , 1997, The American journal of cardiology.

[20]  W. Frishman,et al.  Right-sided valvular endocarditis: etiology, diagnosis, and an approach to therapy. , 1986, American heart journal.

[21]  M Berger,et al.  Right-sided Endocarditis in Intravenous Drug Users , 1992, Annals of Internal Medicine.

[22]  R A Weinstein,et al.  Infective endocarditis in injection drug users: importance of human immunodeficiency virus serostatus and degree of immunosuppression. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J D Thomas,et al.  Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. , 1991, Journal of the American College of Cardiology.

[24]  J. Miro,et al.  Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. , 2002, Infectious disease clinics of North America.

[25]  V. Soriano,et al.  [Study of 164 episodes of infectious endocarditis in drug addicts: comparison of HIV positive and negative patients]. , 1994, Revista clínica española (Ed. impresa).

[26]  J Nikoskelainen,et al.  Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. , 2000, Archives of internal medicine.

[27]  F. D. De Rosa,et al.  Infective endocarditis in patients with human immunodeficiency virus infection. , 2001, The Journal of infection.

[28]  D. Anderson,et al.  The risk of stroke and death in patients with aortic and mitral valve endocarditis. , 2001, American heart journal.

[29]  W. Kannel,et al.  The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.

[30]  L. Baddour,et al.  Polymicrobial infective endocarditis in the 1980s. , 1991, Reviews of infectious diseases.

[31]  A. Bolger,et al.  Prevention of bacterial endocarditis. Recommendations by the American Heart Association. , 1997, Journal of the American Medical Association (JAMA).

[32]  J. Mills,et al.  The role of valve replacement in the treatment of fungal endocarditis. , 1975, The Journal of thoracic and cardiovascular surgery.

[33]  R. Waugh,et al.  Value of transthoracic echocardiography in predicting embolic events in active infective endocarditis. Duke Endocarditis Service. , 1994, The American journal of cardiology.

[34]  K. Bailey,et al.  Emboli in infective endocarditis: the prognostic value of echocardiography. , 1991, Annals of internal medicine.